Mizoribine: A New Approach in the Treatment of Renal Disease
Mizoribine (MZB) is an imidazole nucleoside and an immunosuppressive agent. The immunosuppressive effect of MZB has been reported to be due to the inhibition of DNA synthesis in the S phase of the cell cycle. Because of its relative lack of toxicity, during the past decade MZB has been frequently us...
Saved in:
| Main Author: | Yukihiko Kawasaki |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2009-01-01
|
| Series: | Clinical and Developmental Immunology |
| Online Access: | http://dx.doi.org/10.1155/2009/681482 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Clinical efficacy of mizoribine tablets for treatment of pediatric purpura nephritis
by: 丁娟娟, et al.
Published: (2019-01-01) -
Formononetin and mizoribine inhibit Porcine Reproductive and Respiratory Syndrome Virus replication in vitro
by: Zhanding Cui, et al.
Published: (2025-03-01) -
IgG4-Related Tubulointerstitial Nephritis Associated with Membranous Nephropathy in Two Patients: Remission after Administering a Combination of Steroid and Mizoribine
by: Kana N. Miyata, et al.
Published: (2014-01-01) -
Effects of mizoribine tablets on expression of Toll-like receptor 4 in peripheral blood mononuclear cells in children with Henoch-Sch■nlein purpura nephritis
by: 丁娟娟, et al.
Published: (2020-01-01) -
PROGRAMMED APPROACH TO THE TREATMENT OF SECONDARY HYPERPARATHYROIDISM IN CHRONIC RENAL DISEASE
by: N. A. Samohvalova, et al.
Published: (2018-01-01)